The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Revatio tablets are indicated for treatment of adult patients with pulmonary arterial hypertension (PAH) classified as WHO functional class II and III, to improve exercise capacity. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
